Amazon’s Solimo supplements and personal care line overall is priced higher than Walgreens' brand but lower than CVS', Jefferies Equity Research Americas found. Solimo could present a formidable threat to the supplements category, but its limited assortment so far and pricing should prevent “material market share shifts” in the near-term, Jefferies says.
Amazon.com Inc.’s Solimo dietary supplement line's comparatively limited selection and generally higher prices are cooling its potential for grabbing market share, according to Jefferies Equity Research Americas.
Solimo’s lineup of around 30 supplement products and 100 personal care items launched in early 2018 is priced higher than...